SCYNEXIS Inc (SCYX)
1.715
+0.02
(+1.48%)
USD |
NASDAQ |
May 01, 14:20
SCYNEXIS Price: 1.715 for May 1, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 30, 2024 | 1.79 | 1.80 | 1.68 | 1.69 | 230793.0 |
| Apr 29, 2024 | 1.56 | 1.95 | 1.553 | 1.82 | 438724.0 |
| Apr 26, 2024 | 1.45 | 1.59 | 1.45 | 1.54 | 157721.0 |
| Apr 25, 2024 | 1.48 | 1.490 | 1.42 | 1.47 | 120233.0 |
| Apr 24, 2024 | 1.58 | 1.594 | 1.48 | 1.50 | 87668.00 |
| Apr 23, 2024 | 1.48 | 1.606 | 1.48 | 1.55 | 153695.0 |
| Apr 22, 2024 | 1.45 | 1.48 | 1.44 | 1.44 | 72655.00 |
| Apr 19, 2024 | 1.41 | 1.470 | 1.39 | 1.44 | 130980.0 |
| Apr 18, 2024 | 1.43 | 1.477 | 1.39 | 1.405 | 79920.00 |
| Apr 17, 2024 | 1.40 | 1.46 | 1.37 | 1.42 | 127425.0 |
| Apr 16, 2024 | 1.47 | 1.50 | 1.40 | 1.41 | 106303.0 |
| Apr 15, 2024 | 1.49 | 1.52 | 1.43 | 1.47 | 128518.0 |
| Apr 12, 2024 | 1.61 | 1.63 | 1.44 | 1.445 | 496787.0 |
| Apr 11, 2024 | 1.61 | 1.61 | 1.55 | 1.60 | 144836.0 |
| Apr 10, 2024 | 1.60 | 1.63 | 1.56 | 1.58 | 144685.0 |
| Apr 09, 2024 | 1.66 | 1.67 | 1.58 | 1.63 | 156160.0 |
| Apr 08, 2024 | 1.72 | 1.72 | 1.61 | 1.63 | 172242.0 |
| Apr 05, 2024 | 1.69 | 1.79 | 1.670 | 1.71 | 125497.0 |
| Apr 04, 2024 | 1.78 | 1.86 | 1.610 | 1.68 | 320762.0 |
| Apr 03, 2024 | 1.55 | 1.85 | 1.54 | 1.80 | 724503.0 |
| Apr 02, 2024 | 1.46 | 1.58 | 1.41 | 1.45 | 266616.0 |
| Apr 01, 2024 | 1.52 | 1.525 | 1.42 | 1.49 | 284073.0 |
| Mar 28, 2024 | 1.42 | 1.52 | 1.42 | 1.47 | 184086.0 |
| Mar 27, 2024 | 1.41 | 1.46 | 1.40 | 1.425 | 107777.0 |
| Mar 26, 2024 | 1.46 | 1.46 | 1.39 | 1.39 | 82857.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.15
Minimum
Mar 17 2023
15.90
Maximum
May 08 2019
5.622
Average
5.285
Median
Price Benchmarks
| NovaBay Pharmaceuticals Inc | 0.0853 |
| Palatin Technologies Inc | 1.845 |
| iBio Inc | 1.75 |
| Theriva Biologics Inc | 0.40 |
| Oragenics Inc | 1.03 |
Price Related Metrics
| PE Ratio | 1.319 |
| PS Ratio | 0.5919 |
| Price to Book Value | 0.8874 |
| Price to Free Cash Flow | 1.379 |
| Earnings Yield | 75.80% |
| Market Cap | 64.75M |
| Operating PE Ratio | 1.142 |
| Normalized PE Ratio | 1.234 |